Chemours
558 hedge funds and large institutions have $6.1B invested in Chemours in 2018 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 156 increasing their positions, 176 reducing their positions, and 59 closing their positions.
25% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 59
25% more call options, than puts
Call options by funds: $69.9M | Put options by funds: $55.8M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
2% more funds holding
Funds holding: 546 → 558 (+12)
0.61% more ownership
Funds ownership: 76.75% → 77.36% (+0.61%)
10% less capital invested
Capital invested by funds: $6.78B → $6.1B (-$681M)
11% less repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 176
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$121M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
+$68.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.8M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$37.5M |
| 5 |
Goldman Sachs
New York
|
+$31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$197M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$78.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$53.7M |
| 4 |
Renaissance Technologies
New York
|
-$36.1M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$27.4M |
CC Hedge Fund Activity: Q2 2018 in Review
558 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2018, worth a combined $6.1B — down 10% from $6.78B a quarter earlier.
Buyers outnumbered sellers: 74 funds opened new CC positions and 59 closed out — a net gain of 15 holders — while 156 added to existing stakes and 176 trimmed.
The largest buyer was Iridian Asset Management, adding an estimated $121M. The largest seller was Adage Capital Partners, cutting an estimated $197M.
- 558 institutional investors held Chemours (CC) as of Q2 2018, up from 546 in Q1 2018.
- Funds reported $6.1B of Chemours stock for Q2 2018, down 10% quarter-over-quarter.
- 74 funds opened new Chemours positions in Q2 2018 and 59 closed out, a net change of +15 holders.
- The largest Chemours buyer in Q2 2018 was Iridian Asset Management, an estimated $121M added.
- The largest Chemours seller in Q2 2018 was Adage Capital Partners, an estimated $197M sold.
Based on aggregated 13F filings for Q2 2018.